TY - JOUR AU - Sehn, L. H. AU - Gascoyne, R. D. PY - 2015 DA - 2015// TI - Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity JO - Blood VL - 125 UR - https://doi.org/10.1182/blood-2014-05-577189 DO - 10.1182/blood-2014-05-577189 ID - Sehn2015 ER - TY - JOUR AU - Pasqualucci, L. AU - Trifonov, V. AU - Fabbri, G. AU - Ma, J. AU - Rossi, D. AU - Chiarenza, A. PY - 2011 DA - 2011// TI - Analysis of the coding genome of diffuse large B-cell lymphoma JO - Nat Genet VL - 43 UR - https://doi.org/10.1038/ng.892 DO - 10.1038/ng.892 ID - Pasqualucci2011 ER - TY - JOUR AU - Coiffier, B. AU - Sarkozy, C. PY - 2016 DA - 2016// TI - Diffuse large B-cell lymphoma: R-CHOP failure-what to do? JO - Hematology Am Soc Hematol Educ Program VL - 1 UR - https://doi.org/10.1182/asheducation-2016.1.366 DO - 10.1182/asheducation-2016.1.366 ID - Coiffier2016 ER - TY - JOUR AU - Dunleavy, K. PY - 2014 DA - 2014// TI - Double-hit lymphomas: current paradigms and novel treatment approaches JO - Hematology Am Soc Hematol Educ Program VL - 2014 UR - https://doi.org/10.1182/asheducation-2014.1.107 DO - 10.1182/asheducation-2014.1.107 ID - Dunleavy2014 ER - TY - JOUR AU - Swerdlow, S. H. AU - Campo, E. AU - Pileri, S. A. AU - Harris, N. L. AU - Stein, H. AU - Siebert, R. PY - 2016 DA - 2016// TI - The 2016 revision of the World Health Organization classification of lymphoid neoplasms JO - Blood VL - 127 UR - https://doi.org/10.1182/blood-2016-01-643569 DO - 10.1182/blood-2016-01-643569 ID - Swerdlow2016 ER - TY - JOUR AU - Erdmann, T. AU - Klener, P. AU - Lynch, J. T. AU - Grau, M. AU - Vočková, P. AU - Molinsky, J. PY - 2017 DA - 2017// TI - Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCL JO - Blood VL - 130 UR - https://doi.org/10.1182/blood-2016-12-758599 DO - 10.1182/blood-2016-12-758599 ID - Erdmann2017 ER - TY - JOUR AU - Pfeifer, M. AU - Lenz, G. PY - 2013 DA - 2013// TI - PI3K/AKT addiction in subsets of diffuse large B-cell lymphoma JO - Cell Cycle VL - 12 UR - https://doi.org/10.4161/cc.26575 DO - 10.4161/cc.26575 ID - Pfeifer2013 ER - TY - JOUR AU - Davis, R. E. AU - Brown, K. D. AU - Siebenlist, U. AU - Staudt, L. M. PY - 2001 DA - 2001// TI - Constitutive nuclear factor B κ B activity is required for survival of activated B cell–like diffuse large B cell lymphoma cells JO - J Exp Med VL - 194 UR - https://doi.org/10.1084/jem.194.12.1861 DO - 10.1084/jem.194.12.1861 ID - Davis2001 ER - TY - JOUR AU - Ezell, S. A. AU - Wang, S. AU - Bihani, T. AU - Lai, Z. AU - Grosskurth, S. E. AU - Tepsuporn, S. PY - 2016 DA - 2016// TI - Differential regulation of mTOR signaling determines sensitivity to AKT inhibition in diffuse large B cell lymphoma JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.7036 DO - 10.18632/oncotarget.7036 ID - Ezell2016 ER - TY - JOUR AU - Horvilleur, E. AU - Sbarrato, T. AU - Hill, K. AU - Spriggs, R. V. AU - Screen, M. AU - Goodrem, P. J. PY - 2014 DA - 2014// TI - A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma JO - Leukemia VL - 28 UR - https://doi.org/10.1038/leu.2013.295 DO - 10.1038/leu.2013.295 ID - Horvilleur2014 ER - TY - JOUR AU - Demosthenous, C. AU - Han, J. J. AU - Stenson, M. J. AU - Maurer, M. J. AU - Wellik, L. E. AU - Link, B. PY - 2015 DA - 2015// TI - Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.3378 DO - 10.18632/oncotarget.3378 ID - Demosthenous2015 ER - TY - JOUR AU - Bhat, M. AU - Robichaud, N. AU - Hulea, L. AU - Sonenberg, N. AU - Pelletier, J. AU - Topisirovic, I. PY - 2015 DA - 2015// TI - Targeting the translation machinery in cancer JO - Nat Rev Drug Discov VL - 14 UR - https://doi.org/10.1038/nrd4505 DO - 10.1038/nrd4505 ID - Bhat2015 ER - TY - JOUR AU - Proud, C. G. PY - 2015 DA - 2015// TI - Mnks, eIF4E phosphorylation and cancer JO - Biochim Biophys Acta VL - 1849 UR - https://doi.org/10.1016/j.bbagrm.2014.10.003 DO - 10.1016/j.bbagrm.2014.10.003 ID - Proud2015 ER - TY - JOUR AU - Ribeiro, N. AU - Thuaud, F. AU - Nebigil, C. AU - Désaubry, L. PY - 2012 DA - 2012// TI - Recent advances in the biology and chemistry of the flavaglines JO - Bioorg Med Chem VL - 20 UR - https://doi.org/10.1016/j.bmc.2011.10.048 DO - 10.1016/j.bmc.2011.10.048 ID - Ribeiro2012 ER - TY - JOUR AU - Basmadjian, C. AU - Thuaud, F. AU - Ribeiro, N. AU - Désaubry, L. PY - 2013 DA - 2013// TI - Flavaglines: potent anticancer drugs that target prohibitins and the helicase eIF4A JO - Future Med Chem VL - 5 UR - https://doi.org/10.4155/fmc.13.177 DO - 10.4155/fmc.13.177 ID - Basmadjian2013 ER - TY - JOUR AU - Zhu, J. Y. AU - Lavrik, I. N. AU - Mahlknecht, U. AU - Giaisi, M. AU - Proksch, P. AU - Krammer, P. H. PY - 2007 DA - 2007// TI - The traditional Chinese herbal compound rocaglamide preferentially induces apoptosis in leukemia cells by modulation of mitogen-activated protein kinase activities JO - Int J Cancer VL - 121 UR - https://doi.org/10.1002/ijc.22883 DO - 10.1002/ijc.22883 ID - Zhu2007 ER - TY - JOUR AU - Polier, G. AU - Neumann, J. AU - Thuaud, F. AU - Ribeiro, N. AU - Gelhaus, C. AU - Schmidt, H. PY - 2012 DA - 2012// TI - The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2 JO - Chem Biol VL - 19 UR - https://doi.org/10.1016/j.chembiol.2012.07.012 DO - 10.1016/j.chembiol.2012.07.012 ID - Polier2012 ER - TY - JOUR AU - Nijtmans, L. G. AU - Artal, S. M. AU - Grivell, L. A. AU - Coates, P. J. PY - 2002 DA - 2002// TI - The mitochondrial PHB complex: roles in mitochondrial respiratory complex assembly, ageing and degenerative disease JO - Cell Mol Life Sci VL - 59 UR - https://doi.org/10.1007/s00018-002-8411-0 DO - 10.1007/s00018-002-8411-0 ID - Nijtmans2002 ER - TY - JOUR AU - Song, W. AU - Tian, L. AU - Li, S. S. AU - Shen, D. Y. AU - Chen, Q. X. PY - 2014 DA - 2014// TI - The aberrant expression and localization of prohibitin during apoptosis of human cholangiocarcinoma Mz-ChA-1 cells JO - FEBS Lett VL - 588 UR - https://doi.org/10.1016/j.febslet.2013.12.021 DO - 10.1016/j.febslet.2013.12.021 ID - Song2014 ER - TY - JOUR AU - Peng, Y. T. AU - Chen, P. AU - Ouyang, R. Y. AU - Song, L. PY - 2015 DA - 2015// TI - Multifaceted role of prohibitin in cell survival and apoptosis JO - Apoptosis VL - 20 UR - https://doi.org/10.1007/s10495-015-1143-z DO - 10.1007/s10495-015-1143-z ID - Peng2015 ER - TY - JOUR AU - Bavelloni, A. AU - Piazzi, M. AU - Raffini, M. AU - Faenza, I. AU - Blalock, W. L. PY - 2015 DA - 2015// TI - Prohibitin 2: at a communications crossroads JO - IUBMB Life VL - 67 UR - https://doi.org/10.1002/iub.1366 DO - 10.1002/iub.1366 ID - Bavelloni2015 ER - TY - JOUR AU - Rajalingam, K. AU - Wunder, C. AU - Brinkmann, V. AU - Churin, Y. AU - Hekman, M. AU - Sievers, C. PY - 2005 DA - 2005// TI - Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration JO - Nat Cell Biol VL - 7 UR - https://doi.org/10.1038/ncb1283 DO - 10.1038/ncb1283 ID - Rajalingam2005 ER - TY - JOUR AU - Koushyar, S. AU - Jiang, W. G. AU - Dart, D. A. PY - 2015 DA - 2015// TI - Unveiling the potential of prohibitin in cancer JO - Cancer Lett VL - 369 UR - https://doi.org/10.1016/j.canlet.2015.09.012 DO - 10.1016/j.canlet.2015.09.012 ID - Koushyar2015 ER - TY - JOUR AU - Ross, J. A. AU - Robles-Escajeda, E. AU - Oaxaca, D. M. AU - Padilla, D. L. AU - Kirken, R. A. PY - 2017 DA - 2017// TI - The prohibitin protein complex promotes mitochondrial stabilization and cell survival in hematologic malignancies JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.18920 DO - 10.18632/oncotarget.18920 ID - Ross2017 ER - TY - JOUR AU - Ross, J. A. AU - Nagy, Z. S. AU - Kirken, R. A. PY - 2008 DA - 2008// TI - The PHB1/2 phosphocomplex is required for mitochondrial homeostasis and survival of human T cells JO - J Bio Chem VL - 283 UR - https://doi.org/10.1074/jbc.M708232200 DO - 10.1074/jbc.M708232200 ID - Ross2008 ER - TY - JOUR AU - Campo, E. AU - Swerdlow, S. H. AU - Harris, N. L. AU - Pileri, S. AU - Stein, H. AU - Jaffe, E. S. PY - 2011 DA - 2011// TI - The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications JO - Blood VL - 117 UR - https://doi.org/10.1182/blood-2011-01-293050 DO - 10.1182/blood-2011-01-293050 ID - Campo2011 ER - TY - JOUR AU - Hans, C. P. AU - Weisenburger, D. D. AU - Greiner, T. C. AU - Gascoyne, R. D. AU - Delabie, J. AU - Ott, G. PY - 2004 DA - 2004// TI - Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray JO - Blood VL - 103 UR - https://doi.org/10.1182/blood-2003-05-1545 DO - 10.1182/blood-2003-05-1545 ID - Hans2004 ER - TY - JOUR AU - Dubanet, L. AU - Bentayeb, H. AU - Petit, B. AU - Olivrie, A. AU - Saada, S. AU - Cruz-Morcillo, M. A. PY - 2015 DA - 2015// TI - Anti-apoptotic role and clinical relevance of neurotrophins in diffuse large B-cell lymphomas JO - Br J Cancer VL - 113 UR - https://doi.org/10.1038/bjc.2015.274 DO - 10.1038/bjc.2015.274 ID - Dubanet2015 ER - TY - JOUR AU - Saada, S. AU - Marget, P. AU - Fauchais, A. L. AU - Lise, M. C. AU - Chemin, G. AU - Sindou, P. PY - 2012 DA - 2012// TI - Differential expression of neurotensin and specific receptors, NTSR1 and NTSR2, in normal and malignant human B lymphocytes JO - J Immunol VL - 189 UR - https://doi.org/10.4049/jimmunol.1102937 DO - 10.4049/jimmunol.1102937 ID - Saada2012 ER - TY - JOUR AU - Thuaud, F. AU - Bernard, Y. AU - Türkeri, G. AU - Dirr, R. AU - Aubert, G. AU - Cresteil, T. PY - 2009 DA - 2009// TI - Synthetic analogue of rocaglaol displays a potent and selective cytotoxicity in cancer cells: involvement of apoptosis inducing factor and caspase-12 JO - J Med Chem VL - 52 UR - https://doi.org/10.1021/jm900365v DO - 10.1021/jm900365v ID - Thuaud2009 ER - TY - JOUR AU - Bellanger, C. AU - Dubanet, L. AU - Lise, M. C. AU - Fauchais, A. L. AU - Bordessoule, D. AU - Jauberteau, M. O. PY - 2011 DA - 2011// TI - Endogenous neurotrophins and Trk signaling in diffuse large B cell lymphoma cell lines are involved in sensitivity to rituximab-induced apoptosis JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0027213 DO - 10.1371/journal.pone.0027213 ID - Bellanger2011 ER - TY - JOUR AU - Troutaud, D. AU - Petit, B. AU - Bellanger, C. AU - Marin, B. AU - Gourin-Chaury, M. P. AU - Petit, D. PY - 2010 DA - 2010// TI - Prognostic significance of Bad and AIF apoptotic pathways in diffuse large B-cell lymphoma JO - Clin Lymphoma Myeloma Leuk VL - 10 UR - https://doi.org/10.3816/CLML.2010.n.016 DO - 10.3816/CLML.2010.n.016 ID - Troutaud2010 ER - TY - JOUR AU - Drexler, H. G. AU - Eberth, S. AU - Nagel, S. AU - MacLeod, R. A. PY - 2016 DA - 2016// TI - Malignant hematopoietic cell lines: in vitro models for double-hit B-cell lymphomas JO - Leuk Lymphoma VL - 57 UR - https://doi.org/10.3109/10428194.2015.1108414 DO - 10.3109/10428194.2015.1108414 ID - Drexler2016 ER - TY - JOUR AU - Qureshi, R. AU - Yildirim, O. AU - Gasser, A. AU - Basmadjian, C. AU - Zhao, Q. AU - Wilmet, J. P. PY - 2015 DA - 2015// TI - FL3, a synthetic flavagline and ligand of prohibitins, protects cardiomyocytes via STAT3 from doxorubicin toxicity JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0141826 DO - 10.1371/journal.pone.0141826 ID - Qureshi2015 ER - TY - JOUR AU - Boussemart, L. AU - Malka-Mahieu, H. AU - Girault, I. AU - Allard, D. AU - Hemmingsson, O. AU - Tomasic, G. PY - 2014 DA - 2014// TI - eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies JO - Nature VL - 513 UR - https://doi.org/10.1038/nature13572 DO - 10.1038/nature13572 ID - Boussemart2014 ER - TY - JOUR AU - Yuan, G. AU - Chen, X. AU - Liu, Z. AU - Wei, W. AU - Shu, Q. AU - Abou-Hamdan, H. PY - 2018 DA - 2018// TI - Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway JO - J Exp Clin Cancer Res VL - 37 UR - https://doi.org/10.1186/s13046-018-0695-5 DO - 10.1186/s13046-018-0695-5 ID - Yuan2018 ER - TY - JOUR AU - Jiang, L. AU - Dong, P. AU - Zhang, Z. AU - Li, C. AU - Li, Y. AU - Liao, Y. PY - 2015 DA - 2015// TI - Akt phosphorylates prohibitin 1 to mediate its mitochondrial localization and promote proliferation of bladder cancer cells JO - Cell Death Dis VL - 6 UR - https://doi.org/10.1038/cddis.2015.40 DO - 10.1038/cddis.2015.40 ID - Jiang2015 ER - TY - JOUR AU - Tomita, A. PY - 2016 DA - 2016// TI - Genetic and epigenetic modulation of CD20 expression in B-cell malignancies: molecular mechanisms and significance to rituximab resistance JO - J Clin Exp Hematop VL - 56 UR - https://doi.org/10.3960/jslrt.56.89 DO - 10.3960/jslrt.56.89 ID - Tomita2016 ER - TY - JOUR AU - Zi Xu, Y. X. AU - Ande, S. R. AU - Mishra, S. PY - 2018 DA - 2018// TI - Prohibitin: a new player in immunometabolism and in linking obesity and inflammation with cancer JO - Cancer Lett VL - 415 UR - https://doi.org/10.1016/j.canlet.2017.12.001 DO - 10.1016/j.canlet.2017.12.001 ID - Zi Xu2018 ER - TY - JOUR AU - Theiss, A. L. AU - Sitaraman, S. V. PY - 2011 DA - 2011// TI - The role and therapeutic potential of prohibitin in disease JO - Biochim Biophys Acta VL - 1813 UR - https://doi.org/10.1016/j.bbamcr.2011.01.033 DO - 10.1016/j.bbamcr.2011.01.033 ID - Theiss2011 ER - TY - JOUR AU - Yurugi, H. AU - Marini, F. AU - Weber, C. AU - David, K. AU - Zhao, Q. AU - Binder, H. PY - 2017 DA - 2017// TI - Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours JO - Oncogene VL - 36 UR - https://doi.org/10.1038/onc.2017.93 DO - 10.1038/onc.2017.93 ID - Yurugi2017 ER - TY - JOUR AU - Jazirehi, A. R. AU - Vega, M. I. AU - Chatterjee, D. AU - Goodglick, L. AU - Bonavida, B. PY - 2004 DA - 2004// TI - Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of nonHodgkin’s lymphoma B cells by rituximab JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-03-3500 DO - 10.1158/0008-5472.CAN-03-3500 ID - Jazirehi2004 ER - TY - JOUR AU - Lucas, D. M. AU - Edwards, R. B. AU - Lozanski, G. AU - West, D. A. AU - Shin, J. D. AU - Vargo, M. A. PY - 2009 DA - 2009// TI - The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2008-09-175430 DO - 10.1182/blood-2008-09-175430 ID - Lucas2009 ER - TY - JOUR AU - Bernard, Y. AU - Ribeiro, N. AU - Thuaud, F. AU - Türkeri, G. AU - Dirr, R. AU - Boulberdaa, M. PY - 2011 DA - 2011// TI - Flavaglines alleviate doxorubicin cardiotoxicity: implication of Hsp27 JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0025302 DO - 10.1371/journal.pone.0025302 ID - Bernard2011 ER - TY - JOUR AU - Bhalla, S. AU - Evens, A. M. AU - Dai, B. AU - Prachand, S. AU - Gordon, L. I. AU - Gartenhaus, R. B. PY - 2011 DA - 2011// TI - The novel anti-MEK small molecule AZD6244 induces BIM-dependent and AKT-independent apoptosis in diffuse large B-cell lymphoma JO - Blood VL - 118 UR - https://doi.org/10.1182/blood-2011-03-340109 DO - 10.1182/blood-2011-03-340109 ID - Bhalla2011 ER - TY - JOUR AU - Landon, A. L. AU - Muniandy, P. A. AU - Shetty, A. C. AU - Lehrmann, E. AU - Volpon, L. AU - Houng, S. PY - 2014 DA - 2014// TI - MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL JO - Nat Commun VL - 5 UR - https://doi.org/10.1038/ncomms6413 DO - 10.1038/ncomms6413 ID - Landon2014 ER - TY - JOUR AU - Bordeleau, M. E. AU - Robert, F. AU - Gerard, B. AU - Lindqvist, L. AU - Chen, S. M. AU - Wendel, H. G. PY - 2008 DA - 2008// TI - Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model JO - J Clin Invest VL - 118 ID - Bordeleau2008 ER - TY - JOUR AU - Cencic, R. AU - Robert, F. AU - Galicia-Vázquez, G. AU - Malina, A. AU - Ravindar, K. AU - Somaiah, R. PY - 2013 DA - 2013// TI - Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4A JO - Blood Cancer J VL - 3 UR - https://doi.org/10.1038/bcj.2013.25 DO - 10.1038/bcj.2013.25 ID - Cencic2013 ER - TY - JOUR AU - Wolfe, A. L. AU - Singh, K. AU - Zhong, Y. AU - Drewe, P. AU - Rajasekhar, V. K. AU - Sanghvi, V. R. PY - 2014 DA - 2014// TI - RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer JO - Nature VL - 513 UR - https://doi.org/10.1038/nature13485 DO - 10.1038/nature13485 ID - Wolfe2014 ER - TY - JOUR AU - Lin, C. J. AU - Nasr, Z. AU - Premsrirut, P. K. AU - Porco, J. A. AU - Hippo, Y. AU - Lowe, S. W. PY - 2012 DA - 2012// TI - Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis JO - Cell Rep VL - 1 UR - https://doi.org/10.1016/j.celrep.2012.02.010 DO - 10.1016/j.celrep.2012.02.010 ID - Lin2012 ER - TY - JOUR AU - Sarkozy, C. AU - Traverse-Glehen, A. AU - Coiffier, B. PY - 2015 DA - 2015// TI - Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)00005-4 DO - 10.1016/S1470-2045(15)00005-4 ID - Sarkozy2015 ER - TY - JOUR AU - Duyao, M. P. AU - Buckler, A. J. AU - Sonenshein, G. E. PY - 1990 DA - 1990// TI - Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter JO - Proc Natl Acad Sci U S A VL - 87 UR - https://doi.org/10.1073/pnas.87.12.4727 DO - 10.1073/pnas.87.12.4727 ID - Duyao1990 ER - TY - JOUR AU - Steinhardt, J. J. AU - Peroutka, R. J. AU - Mazan-Mamczarz, K. AU - Chen, Q. AU - Houng, S. AU - Robles, C. PY - 2014 DA - 2014// TI - Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2014-07-589689 DO - 10.1182/blood-2014-07-589689 ID - Steinhardt2014 ER - TY - JOUR AU - Sripathi, S. R. AU - He, W. AU - Atkinson, C. L. AU - Smith, J. J. AU - Liu, Z. AU - Elledge, B. M. PY - 2011 DA - 2011// TI - Mitochondrial-nuclear communication by prohibitin shuttling under oxidative stress JO - Biochemistry VL - 50 UR - https://doi.org/10.1021/bi2008933 DO - 10.1021/bi2008933 ID - Sripathi2011 ER - TY - JOUR AU - Thomas, M. P. AU - Liu, X. AU - Whangbo, J. AU - McCrossan, G. AU - Sanborn, K. B. AU - Basar, E. PY - 2015 DA - 2015// TI - Apoptosis triggers specific, rapid, and global mRNA decay with 3’Uridylated intermediates degraded by DIS3L2 JO - Cell Rep VL - 11 UR - https://doi.org/10.1016/j.celrep.2015.04.026 DO - 10.1016/j.celrep.2015.04.026 ID - Thomas2015 ER -